{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:01Z","timestamp":1791576121515,"version":"4.3.4"},"reference-count":60,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009032","name":"Pfizer Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Several long-acting growth hormone (LAGH) therapies have recently become available, but guidance on their usage in children with growth hormone (GH) deficiency is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>International experts in pediatric endocrinology were invited to join a consensus group based on their expertise in treating children with daily GH and LAGH. The group comprised 11 experts from 10 countries across the world. Online group meetings were held in February to March 2024 followed by a 1-day in-person meeting in May 2024 to finalize the consensus recommendations. A targeted literature search approach was used to identify and share evidence ahead of the meetings. Formulations considered were limited to those with international populations in phase III pivotal trials and regulatory approvals in multiple countries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence synthesis<\/jats:title>\n                  <jats:p>Topics covered include patient selection and preference, dose adjustment, initiating and switching therapies, administration, adherence and missed doses, practical considerations, and knowledge gaps. LAGH formulations offer a potential advantage over daily GH injections for children with GH deficiency in terms of reduced injection frequency and treatment burden; this may also be associated with improved adherence and treatment outcomes over time. However, data on LAGH in pediatric GH deficiency are mostly limited to clinical trials, and long-term, real-world data are currently lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This article provides an international consensus on the use of LAGH therapy in children with GH deficiency to guide practitioners when considering these new treatment options for their patients. Long-term data are needed to fill current data gaps and allow the creation of comprehensive evidence-based recommendations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae834","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T01:51:51Z","timestamp":1734141111000},"page":"e1232-e1240","source":"Crossref","is-referenced-by-count":45,"title":["Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-8579","authenticated-orcid":false,"given":"Aristides","family":"Maniatis","sequence":"first","affiliation":[{"name":"Rocky Mountain Pediatric Endocrinology , Centennial, CO 80112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-3682","authenticated-orcid":false,"given":"Wayne","family":"Cutfield","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland , Auckland 1142 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dattani","sequence":"additional","affiliation":[{"name":"Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health , London WC1N 1EH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri","family":"Deal","sequence":"additional","affiliation":[{"name":"Centre de recherche CHU Ste-Justine, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al H3T 1C5 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Ferrez","family":"Collett-Solberg","sequence":"additional","affiliation":[{"name":"Disciplina de Endocrinologia, Departamento de Medicina Interna, Faculdade de Ci\u00eancias Medicas, Universidade do Estado do Rio de Janeiro , Rio de Janeiro 20550-170 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-3246","authenticated-orcid":false,"given":"Reiko","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, National Center for Child Health and Development , Tokyo 157-8535 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-5238","authenticated-orcid":false,"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, IRCCS Istituto Giannina Gaslini , 16147 Genova ,","place":["Italy"]},{"name":"Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genova , 16147 Genova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-5473","authenticated-orcid":false,"given":"Bradley S","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, M Health Fairview Masonic Children's Hospital , Minneapolis, MN 55454 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, Gyn\u00e9cologie et Diab\u00e9tologie P\u00e9diatriques, H\u00f4pital Universitaire Necker Enfants Malades, AP-HP, Universit\u00e9 Paris Cit\u00e9 , 75015 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"S\u00e4vendahl","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital , 171 77 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Woelfle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University (FAU) Erlangen-N\u00fcrnberg , 91054 Erlangen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"8483","key":"2025041605365719800_dgae834-B1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(86)91098-6","article-title":"Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children","volume":"327","author":"Kaplan","year":"1986","journal-title":"Lancet"},{"issue":"11","key":"2025041605365719800_dgae834-B2","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","author":"Growth Hormone Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025041605365719800_dgae834-B3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2025041605365719800_dgae834-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6065\/apem.2014.19.1.1","article-title":"Growth hormone treatment in non-growth hormone-deficient children","volume":"19","author":"Loche","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"2025041605365719800_dgae834-B5","doi-asserted-by":"crossref","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","article-title":"Non-compliance with growth hormone treatment in children is common and impairs linear growth","volume":"6","author":"Cutfield","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"2025041605365719800_dgae834-B6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000524600","article-title":"Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin\u00ae) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study","volume":"95","author":"Horikawa","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"2025041605365719800_dgae834-B7","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/clinem\/dgac513","article-title":"Weekly somapacitan is effective and well tolerated in children with GH deficiency: the randomized phase 3 REAL4 trial","volume":"107","author":"Miller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025041605365719800_dgae834-B8","doi-asserted-by":"crossref","first-page":"e2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025041605365719800_dgae834-B9","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment-na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025041605365719800_dgae834-B10","doi-asserted-by":"crossref","first-page":"e0278293","DOI":"10.1371\/journal.pone.0278293","article-title":"Experience of switching from a daily to a less frequent administration of injection treatments","volume":"17","author":"Loftus","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"2025041605365719800_dgae834-B11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1530\/EC-18-0172","article-title":"Adherence and long-term growth outcomes: results from the easypod\u2122 connect observational study (ECOS) in paediatric patients with growth disorders","volume":"7","author":"Koledova","year":"2018","journal-title":"Endocr Connect"},{"issue":"6","key":"2025041605365719800_dgae834-B12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eprac.2022.02.013","article-title":"Association of daily growth hormone injection adherence and height among children with growth hormone deficiency","volume":"28","author":"Loftus","year":"2022","journal-title":"Endocr Pract"},{"issue":"Supplement_1","key":"2025041605365719800_dgae834-B13","doi-asserted-by":"crossref","first-page":"SAT-091","DOI":"10.1210\/jendso\/bvaa046.603","article-title":"SAT-091 First report of disease-specific patient-reported outcomes from a randomized phase 2 trial of once-weekly somapacitan vs daily GH in children with GHD","volume":"4","author":"Brod","year":"2020","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025041605365719800_dgae834-B14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000524003","article-title":"Switching to weekly lonapegsomatropin from daily somatropin in children with growth hormone deficiency: the fliGHt trial","volume":"95","author":"Maniatis","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2025041605365719800_dgae834-B15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/03007995.2023.2290623","article-title":"Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin","volume":"40","author":"Loftus","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2025041605365719800_dgae834-B16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40271-017-0237-9","article-title":"Understanding treatment burden for children treated for growth hormone deficiency","volume":"10","author":"Brod","year":"2017","journal-title":"Patient"},{"issue":"10","key":"2025041605365719800_dgae834-B17","doi-asserted-by":"crossref","first-page":"e14617","DOI":"10.1111\/dme.14617","article-title":"Health-related quality of life in youth with type 1 diabetes: associations with multiple comorbidities and mental health conditions","volume":"38","author":"Shapira","year":"2021","journal-title":"Diabet Med"},{"issue":"1","key":"2025041605365719800_dgae834-B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12969-021-00495-4","article-title":"I don't want to think about it: a qualitative study of children (6-18 years) with rheumatic diseases and parents\u2019 experiences with regular needle injections at home","volume":"19","author":"S\u00f8rensen","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"2025041605365719800_dgae834-B19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/js.2019-00036","article-title":"Treatment of central precocious puberty","volume":"3","author":"Eugster","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025041605365719800_dgae834-B20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.17925\/EE.2023.19.1.38","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes in youth","volume":"19","author":"Berman","year":"2023","journal-title":"touchREV Endocrinol"},{"issue":"2","key":"2025041605365719800_dgae834-B21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000485184","article-title":"A multicenter experience with long-acting somatostatin analogues in patients with congenital hyperinsulinism","volume":"89","author":"van der Steen","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"Supplement_4","key":"2025041605365719800_dgae834-B22","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1093\/cid\/ciac754","article-title":"Potential of long-acting products to transform the treatment and prevention of human immunodeficiency virus (HIV) in infants, children, and adolescents","volume":"75","author":"Abrams","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2025041605365719800_dgae834-B23","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/clinem\/dgad394","article-title":"Effective GH replacement with somapacitan in children with GHD: REAL4 2-year results and after switch from daily GH","volume":"108","author":"Miller","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025041605365719800_dgae834-B24","doi-asserted-by":"crossref","first-page":"bvac117","DOI":"10.1210\/jendso\/bvac117","article-title":"Treatment burden of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a randomized study","volume":"6","author":"Maniatis","year":"2022","journal-title":"J Endocr Soc"},{"key":"2025041605365719800_dgae834-B25","author":"European Medicines Agency"},{"key":"2025041605365719800_dgae834-B26","author":"Food and Drug Administration"},{"key":"2025041605365719800_dgae834-B27","author":"European Medicines Agency"},{"key":"2025041605365719800_dgae834-B28","author":"Food and Drug Administration"},{"key":"2025041605365719800_dgae834-B29","author":"European Medicines Agency"},{"key":"2025041605365719800_dgae834-B30","author":"Food and Drug Administration"},{"issue":"6","key":"2025041605365719800_dgae834-B31","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations\u2014current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025041605365719800_dgae834-B32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jc.2013-2502","article-title":"24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency","volume":"99","author":"Khadilkar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025041605365719800_dgae834-B33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-16-0905","article-title":"Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies","volume":"177","author":"Luo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2025041605365719800_dgae834-B34","doi-asserted-by":"crossref","first-page":"106805","DOI":"10.1016\/j.phrs.2023.106805","article-title":"Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol Res"},{"issue":"2","key":"2025041605365719800_dgae834-B35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2011-2234","article-title":"Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD)","volume":"97","author":"P\u00e9ter","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025041605365719800_dgae834-B36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-13-0148","article-title":"Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency","volume":"169","author":"Hwang","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2025041605365719800_dgae834-B37","doi-asserted-by":"crossref","first-page":"955809","DOI":"10.3389\/fphar.2022.955809","article-title":"Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: a randomized, dose-comparison study","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025041605365719800_dgae834-B38","doi-asserted-by":"crossref","first-page":"821588","DOI":"10.3389\/fendo.2022.821588","article-title":"PEGylated recombinant human growth hormone jintrolong\u00ae exhibits good long-term safety in cynomolgus monkeys and human pediatric growth hormone deficiency patients","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025041605365719800_dgae834-B39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12911-020-01183-1","article-title":"Analysis of real-world data on growth hormone therapy adherence using a connected injection device","volume":"20","author":"Koledova","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"issue":"12","key":"2025041605365719800_dgae834-B40","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1080\/03007995.2021.1982682","article-title":"Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency","volume":"37","author":"Loftus","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"2025041605365719800_dgae834-B41","doi-asserted-by":"crossref","first-page":"980979","DOI":"10.3389\/fendo.2022.980979","article-title":"What do we do now that the long-acting growth hormone is here?","volume":"13","author":"Miller","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2025041605365719800_dgae834-B42","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/clinem\/dgad079","article-title":"Childhood-onset craniopharyngioma: when to initiate GH replacement therapy?","volume":"108","author":"Nguyen Quoc","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025041605365719800_dgae834-B43","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2025041605365719800_dgae834-B44","doi-asserted-by":"crossref","first-page":"637209","DOI":"10.3389\/fendo.2021.637209","article-title":"Usefulness and potential pitfalls of long-acting growth hormone analogs","volume":"12","author":"Yuen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2025041605365719800_dgae834-B45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000530522","article-title":"Weekly growth hormone (lonapegsomatropin) causes severe transient hyperglycemia in a child with obesity","volume":"96","author":"Alkhatib","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2025041605365719800_dgae834-B46","doi-asserted-by":"crossref","first-page":"bvab168","DOI":"10.1210\/jendso\/bvab168","article-title":"Average IGF-1 prediction for once-weekly lonapegsomatropin in children with growth hormone deficiency","volume":"6","author":"Lin","year":"2021","journal-title":"J Endocr Soc"},{"issue":"11","key":"2025041605365719800_dgae834-B47","doi-asserted-by":"crossref","first-page":"bvad115","DOI":"10.1210\/jendso\/bvad115","article-title":"Model-based analysis of IGF-I response, dosing, and monitoring for once-weekly somapacitan in children with GH deficiency","volume":"7","author":"Kildemoes","year":"2023","journal-title":"J Endocr Soc"},{"key":"2025041605365719800_dgae834-B48","doi-asserted-by":"crossref","first-page":"101592","DOI":"10.1016\/j.ghir.2024.101592","article-title":"Pediatric growth hormone deficiency: understanding the patient and caregiver perspectives","volume":"76","author":"Miller","year":"2024","journal-title":"Growth Horm IGF Res"},{"key":"2025041605365719800_dgae834-B49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fendo.2018.00688","article-title":"Shared decision-making in growth hormone therapy-implications for patient care","volume":"9","author":"Acerini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 4","key":"2025041605365719800_dgae834-B50","first-page":"455","article-title":"LB17 the majority of children with pediatric growth hormone deficiency treated with lonapegsomatropin for up to 6 years met or exceeded average parental height SDS: final results of enliGHten","volume":"96","author":"Vlachopapadopoulou","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"Supplement_1","key":"2025041605365719800_dgae834-B51","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad114.1522","article-title":"OR21-04 long-term efficacy and safety of once-weekly somatrogon in pediatric subjects with growth hormone deficiency: results from up to 8 years of somatrogon treatment","volume":"7","author":"Zadik","year":"2023","journal-title":"J Endocr Soc"},{"issue":"10","key":"2025041605365719800_dgae834-B52","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/clinem\/dgad183","article-title":"Weekly somapacitan in GH deficiency: 4-year efficacy, safety, and treatment\/disease burden results from REAL 3","volume":"108","author":"S\u00e4vendahl","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025041605365719800_dgae834-B53","doi-asserted-by":"crossref","first-page":"e2680","DOI":"10.1210\/clinem\/dgac217","article-title":"Safety and efficacy of lonapegsomatropin in children with growth hormone deficiency: enliGHten trial 2-year results","volume":"107","author":"Maniatis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025041605365719800_dgae834-B54","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/clinem\/dgab928","article-title":"Effective GH replacement with once-weekly somapacitan vs daily GH in children with GHD: 3-year results from REAL 3","volume":"107","author":"S\u00e4vendahl","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025041605365719800_dgae834-B55","author":"GloBE-Reg"},{"issue":"4","key":"2025041605365719800_dgae834-B56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000533763","article-title":"Development of a minimum dataset for the monitoring of recombinant human growth hormone (rhGH) therapy use in children with growth hormone deficiency (GHD)\u2014a GloBE-Reg initiative","volume":"97","author":"Chen","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"2025041605365719800_dgae834-B57","author":"GloBE-Reg"},{"issue":"Supplement_1","key":"2025041605365719800_dgae834-B58","doi-asserted-by":"crossref","first-page":"A630","DOI":"10.1210\/jendso\/bvac150.1306","article-title":"PMON336 Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): a multi-country, non-interventional, prospective, cohort study of patients receiving human growth hormone treatments under routine clinical care","volume":"6","author":"Geffner","year":"2022","journal-title":"J Endocr Soc"},{"key":"2025041605365719800_dgae834-B59","author":"ClinicalTrials.gov","year":"2024"},{"key":"2025041605365719800_dgae834-B60","author":"Backeljauw"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae834\/61156536\/dgae834.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1232\/61156536\/dgae834.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1232\/61156536\/dgae834.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:37:11Z","timestamp":1744796231000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/e1232\/7915788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,3]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae834","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,12,3]]}}}